Colonisation Factor CD0873, an Attractive Oral Vaccine Candidate against Clostridioides difficile

作者: Cansu Karyal , Jaime Hughes , Michelle L Kelly , Jeni C Luckett , Philip V Kaye

DOI: 10.3390/MICROORGANISMS9020306

关键词: CecumAntigenHamsterImmunologyToxinAntibodyPseudomembranous colitisTiterToxic megacolonMedicine

摘要: Clostridioides difficile is the main cause of health-care-associated infectious diarrhoea. Toxins, TcdA and TcdB, secreted by this bacterium damage colonic epithelial cells in severe cases culminates pseudomembranous colitis, toxic megacolon death. Vaccines human trials have focused exclusively on parenteral administration toxin-based formulations. These vaccines promote toxin-neutralising serum antibodies but fail to confer protection from infection gut. An effective route immunise against gut pathogens stimulate a protective mucosal antibody response (secretory immunoglobulin A, IgA) at site oral route. Additionally, immunisation generates systemic (IgG). Using route, two different antigens were tested hamster model: The colonisation factor CD0873 TcdB fragment. Animals immunised with generated significantly higher titre sIgA intestinal fluid IgG compared naive animals, which inhibited adherence C. Caco-2 cells. Following challenge hypervirulent isolate, CD0873-immunised group showed mean increase 80% time experimental endpoint animals. Survival body condition correlated bacterial clearance reduced pathology cecum. Our findings advocate as promising vaccine candidate difficile.

参考文章(73)
Iouri F Belyi, Nina A Varfolomeeva, Construction of a fusion protein carrying antigenic determinants of enteric clostridial toxins Fems Microbiology Letters. ,vol. 225, pp. 325- 329 ,(2003) , 10.1016/S0378-1097(03)00560-3
Daniel Newsted, Firouzeh Fallahi, Ashkan Golshani, Ali Azizi, Advances and challenges in mucosal adjuvant technology. Vaccine. ,vol. 33, pp. 2399- 2405 ,(2015) , 10.1016/J.VACCINE.2015.03.096
A J Macpherson, K D McCoy, F-E Johansen, P Brandtzaeg, The immune geography of IgA induction and function Mucosal Immunology. ,vol. 1, pp. 11- 22 ,(2008) , 10.1038/MI.2007.6
Stuart Johnson, Dale N. Gerding, Mary M. Olson, Mary D. Weiler, Rita A. Hughes, Connie R. Clabots, Lance R. Peterson, Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission The American Journal of Medicine. ,vol. 88, pp. 137- 140 ,(1990) , 10.1016/0002-9343(90)90462-M
Christina Marciniak, David Chen, Adam C. Stein, Patrick E. Semik, Prevalence of Clostridium Difficile Colonization at Admission to Rehabilitation Archives of Physical Medicine and Rehabilitation. ,vol. 87, pp. 1086- 1090 ,(2006) , 10.1016/J.APMR.2006.03.020
Yuan-Pin Hung, Hsiao-Ju Lin, Tai-Chieh Wu, Hsiu-Chuan Liu, Jen-Chieh Lee, Chih-I Lee, Yi-Hui Wu, Lei Wan, Pei-Jane Tsai, Wen-Chien Ko, None, Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure PLoS ONE. ,vol. 8, pp. e69577- ,(2013) , 10.1371/JOURNAL.PONE.0069577
Hercules Moura, Rebecca R Terilli, Adrian R Woolfitt, Yulanda M Williamson, Glauber Wagner, Thomas A Blake, Maria I Solano, John R Barr, None, Proteomic Analysis and Label-Free Quantification of the Large Clostridium difficile Toxins International Journal of Proteomics. ,vol. 2013, pp. 293782- 293782 ,(2013) , 10.1155/2013/293782
Carol Kilkenny, William J. Browne, Innes C. Cuthill, Michael Emerson, Douglas G. Altman, Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research PLoS Biology. ,vol. 8, pp. e1000412- 99 ,(2010) , 10.1371/JOURNAL.PBIO.1000412